CD4 and tuberculosis: In order to determine the significance of our findings and investigate RelMtb antigen presentation by APCs during TB treatment in the mammalian host, we studied RelMtb-reactive CD4+ T-cell responses in the lungs of Mtb-infected mice treated with isoniazid.